Jun. 23 at 1:13 AM
$PFE paid
$43B for Seagen in 2023 just to watch their main ADC flop TONIGHT after hours, opening the door for SLS.
If
$SLS captures even half of that value at
$20B, with their 196.6M share count that puts the stock price over
$101.
At
$20 Billion Valuation:
$101.71 per share
At
$40 Billion Valuation:
$203.42 per share
$PFE CEO is NOW desperate AF for a lifeline, while
$MRK $JNJ $LLY jump in the fight for oncology dominance.
A massive bidding war is gearing up, though
$SLS could easily go it alone with blockbuster patents expiring everywhere in 2027 and 2028.
Throw in High Cost to Borrow (CTB) flagging a short squeeze BEFORE we get the 80th even happens.....Hold on to your hats this shit is gonna be crrraazzzzzy. 💣🚀
